GL1X · GenesisL1 explorer

MolNFT v1 · #88227 · protein

Macrocyclic transition-state mimicking HIV-1 protease inhibitors encompassing a tertiary alcohol

4COE: “Macrocyclic transition-state mimicking HIV-1 protease inhibitors encompassing a tertiary alcohol”. X-ray diffraction, 2 ligands (M17, CL), 1 pocket (best druggability 0.72). MolNFT v1 #88227 on GenesisL1: 3D structure, binding sites…

PDB
4COE
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
EC
3.4.23.16
UniProt
P03366
Ligands
M17, CL
Pockets
1 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 56% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtease (EC 3.4.23.16)protein994% helix, 56% strandP03366

Ligands and binding sites

  • M17 · methyl {(2S)-1-[2-(biphenyl-4-ylmethyl)-2-{(4R)-4-hydroxy-5-{[(2S)-3-methyl-1-oxo-1-(prop-2-en-1-ylamino)butan-2-yl]amino}-5-oxo-4-[4-(prop-2-en-1-yl)benzyl]pentyl}hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate · ligand · chains A, B
  • CL · Chloride ion · ion · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14050.720.8338M17

Interfaces

1 interface between chains.

  • A–B · 1851 Ų buried · 44 hydrogen bonds · protein-protein

Compared structures

  • 4COE · Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.